Samuel C. Blackman - HEAD OF R&D at Day One Biopharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Head Of R&D
Stock Symbol
DAWN on Nasdaq
All Insider Reports
All Insider Reports

Samuel C. Blackman - trading volume in the past year for Day One Biopharmaceuticals, Inc.

Holdings reported by Samuel C. Blackman for Day One Biopharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.03M $13.8M $13.31 Dec 10, 2024 Direct
Common Stock 1M $13.3M $13.31 Dec 10, 2024 Indirect
Restricted Stock Unit (RSU) 84.9K $1.36M $16.08 May 15, 2024 Direct Common Stock
Restricted Stock Unit (RSU) 72.8K $961K $13.21 Nov 15, 2024 Direct Common Stock
Stock Option (right to buy Common Stock) 148K Jan 5, 2024 Direct Common Stock

Transactions reported by Samuel C. Blackman for Day One Biopharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.